Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Food-dependent exercise-induced anaphylaxis

Food-dependent exercise-induced anaphylaxis Purpose of review The following article provides an overview of food-dependent exercise-induced anaphylaxis (FD-EIAn). The review focuses on the epidemiology, pathophysiology, and clinical findings of FD-EIAn and details current practice in terms of the investigation, management, and treatment options available. Recent findings The management of FD-EIAn has not changed significantly over the last few years and still requires careful investigation by an experienced clinician to ensure that the correct diagnosis is made and appropriate treatment is given. Although new therapies such as synthetic prostaglandin E1 analogs and IgE monoclonal antibodies have been trialed as treatment options for FD-EIAn, the mainstay of treatment remains the graded reintroduction to exercise in a supervised setting. Summary FD-EIAn is a rare but serious condition that can have a significant impact on patients’ lives. This review aims to discuss new relevant research into this field to help guide clinicians in managing this condition. aChildren's Allergy Service, Evelina London Children's Hospital, Guy's and St. Thomas’ NHS Foundation Trust bPediatric Allergy Group, Department of Women and Children's Health, School of Life Course Sciences cPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom dAllergy Unit, Department of Pediatrics, Anna Meyer Children's Hospital, University of Florence, Florence, Italy Correspondence to George du Toit, Children's Allergy Service, Evelina London Children's Hospital, Guy's and St. Thomas’ NHS Foundation Trust, London SE1 7EH, United Kingdom. Tel: +44 2071880145; e-mail: george.dutoit@gstt.nhs.uk http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in Allergy and Clinical Immunology Wolters Kluwer Health

Food-dependent exercise-induced anaphylaxis

Download PDF
5 pages

Loading next page...
 
/lp/wolters-kluwer-health/food-dependent-exercise-induced-anaphylaxis-xIBCvbfSnv

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
ISSN
1528-4050
eISSN
1473-6322
DOI
10.1097/ACI.0000000000000531
Publisher site
See Article on Publisher Site

Abstract

Purpose of review The following article provides an overview of food-dependent exercise-induced anaphylaxis (FD-EIAn). The review focuses on the epidemiology, pathophysiology, and clinical findings of FD-EIAn and details current practice in terms of the investigation, management, and treatment options available. Recent findings The management of FD-EIAn has not changed significantly over the last few years and still requires careful investigation by an experienced clinician to ensure that the correct diagnosis is made and appropriate treatment is given. Although new therapies such as synthetic prostaglandin E1 analogs and IgE monoclonal antibodies have been trialed as treatment options for FD-EIAn, the mainstay of treatment remains the graded reintroduction to exercise in a supervised setting. Summary FD-EIAn is a rare but serious condition that can have a significant impact on patients’ lives. This review aims to discuss new relevant research into this field to help guide clinicians in managing this condition. aChildren's Allergy Service, Evelina London Children's Hospital, Guy's and St. Thomas’ NHS Foundation Trust bPediatric Allergy Group, Department of Women and Children's Health, School of Life Course Sciences cPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom dAllergy Unit, Department of Pediatrics, Anna Meyer Children's Hospital, University of Florence, Florence, Italy Correspondence to George du Toit, Children's Allergy Service, Evelina London Children's Hospital, Guy's and St. Thomas’ NHS Foundation Trust, London SE1 7EH, United Kingdom. Tel: +44 2071880145; e-mail: george.dutoit@gstt.nhs.uk

Journal

Current Opinion in Allergy and Clinical Immunology – Wolters Kluwer Health

Published: Jun 1, 2019

There are no references for this article.